Compare Cassava Sciences Inc (FLNA) vs Lucid Group Inc (LCID) Price & Performance

FLNA trades at $1.06, down 2.75% today, with a bearish technical signal from moving averages but neutral oscillators. The stock shows a low P/B of 0.78, yet profitability metrics are negative, including a -79.59% ROE and -$90.97M net income for 2025. Recent Q1 2026 earnings beat expectations, and analyst consensus is 66.7% buy. News highlights Q1 financial results and a scientific presentation on TSC-related epilepsy therapies.

Outlook remains speculative due to persistent losses and negative cash flows, offset by strong analyst support and recent earnings beats. Key risks include funding needs for drug development and competitive pressures, while potential upside hinges on clinical progress in TSC-related epilepsy treatments.

Lucid Group (LCID) trades at $6.66, up 44.16% in the last session following CEO denial of bankruptcy rumors. The stock shows a neutral technical signal with bullish moving averages but negative oscillators. Fundamentally, the company reports a net loss of $2.70B on $1.35B revenue for 2025, with negative margins across gross profit (-95.6%) and net income (-239.81%). Cash flow remains negative at -$566.14M, though liquidity is claimed sufficient into 2026.

Outlook is highly speculative with significant execution risks. While the recent price surge reflects relief from bankruptcy fears, persistent cash burn, missed earnings, and class-action lawsuits pose substantial downside. Analyst consensus is cautious with a $10.50 price target but only 13.33% buy ratings. Investment hinges on successful midsize EV launch and cost control amid intense competition.